Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | The benefits of investigating allogeneic CAR-T products for patients with B-ALL

Martina Sersch • 14 Apr 2022
AACR 2022
Acute Lymphoblastic Leukemia Leukemia CAR-T TruUCAR™ GC502

Martina Sersch, MD, Gracell Biotechnologies, San Diego, CA, briefly discusses the benefit of allogeneic CAR-T products for patients with B-cell acute lymphoblastic leukemia (B-ALL). Dr Sersch first highlights the rapid disease progression that patients with B-ALL face, and then goes on to discuss the benefits of further investigating allogeneic, readily available CAR-T products. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

More from Martina Sersch

Challenges faced with the production of universal CAR-T products
2:45
Challenges faced with the production of universal CAR-T products
Martina Sersch et al. • 14 Apr 2022

Related Videos

Is there a role for CAR T-cell therapy in the treatment pathway for CLL?
1:21
Is there a role for CAR T-cell therapy in the treatment pathway for CLL?
Marco Ruella • 16 Oct 2026
Access challenges to diagnosis and treatment for patients with CLL in resource-restricted countries
1:45
Access challenges to diagnosis and treatment for patients with CLL in resource-restricted countries
Celso Arrais • 17 Oct 2026
Insights into the current CLL treatment algorithm and emerging research directions
1:51
Insights into the current CLL treatment algorithm and emerging research directions
Matthew Davids • 17 Oct 2026
How has the harmonization of genomic profiling in Sweden impacted patient access to CLL diagnostics?
1:21
How has the harmonization of genomic profiling in Sweden impacted patient access to CLL diagnostics?
Richard Rosenquist • 17 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals